Loading...
Target therapy in treatment of HER2-positive breast cancer
The breast cancer (BC) wins first place in structure of oncological incidence of the female population around the world. The special place is occupied by tumors with a superfluous expression of HER2 of a factor which is defined at 25–30 % of patients. Interest to suchpatients is defined by an aggres...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-02-01
|
| Serier: | Сибирский онкологический журнал |
| Fag: | |
| Online adgang: | https://www.siboncoj.ru/jour/article/view/103 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|